mounjaro patent expiration date tirzepatide These highlights do not include all the information needed to use safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022 Generic Mounjaro®: Timeline for Generic
Description
They share the same receptor pathway, and doubling up dramatically increases the risk of severe gastrointestinal side effects without proportional benefit
An additional 1 in 100 to 1 in 200 users might experience a gallbladder event that would not have happened otherwise
Experiencing unexpected side effects
Foods high in sulfur, such as eggs, garlic, onions, and cruciferous vegetables, can increase the likelihood of sulfur burps
Will insurance cover generic Mounjaro when its available
R., Rodrigo N., Longfield M
